Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer

NCT00966706 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: capecitabine
DRUG: cisplatin
DRUG: docetaxel
DRUG: epirubicin hydrochloride
DRUG: gemcitabine hydrochloride

Sponsor

IRCCS San Raffaele